Rg5 & Rk1

Rg5 & Rk1 : the secret tandem behind black ginseng

1. WHITE, RED OR BLACK GINSENG: A MATTER OF GINSENOSIDES

Ginsenosides are considered to be the main active substances from Panax ginseng roots. However, not all ginsenosides are equal in terms of health benefits. Indeed, the most common ginsenosides like Rb1 or Rg1 have poor bioavailability and therefore limited physiological impact by themselves. That said, it has been discovered that these ginsenosides can be partially converted by gut microbiota to more bioavailable forms of ginsenosides [1-2]. For instance, Rb1 is transformed in Rd which can then be transformed in Rg3, a ginsenoside considered to be bioactive (more info about Rg3 here soon). However, ginsenoside bioconversion by gut microbiota is both variable (depending of the microbiota status of the individual) and partial [3].
 
Alternatively, root processing by single steam cooking (= red ginseng), multiple steam cooking (=black ginseng), fermentation (fermented ginseng) or even enzymatic treatment can transform the ginsenoside profile and produce more bioavailable forms directly in the root, leading to better bioavailability of the active cosntituents [4-7]. For instance, red ginseng contains more Rg3 than white ginseng, black ginseng contains more Rg3 than red and white ginseng. Black ginseng also contains Rg5 & Rk1 (products of the dehydration of Rg3) which are considered to be bioactive forms too. It should be noted that black ginseng, due to the fact that it contains bioactive forms of ginsenosides, has been identified as more performant in a series of conditions and more specifically in the metabolic regulation area [8-12].

2. HEALTH POTENTIAL OF THE TANDEM Rg5:Rk1

2.1. Metabolic regulation

As previously mentionned, black ginseng has been identified as particularly interesting in the context of metabolic regulation, both for its activity on glycemia and on lipid metabolism. These properties has been correlated to bioactive ginsenosides such as Rg3, Rg5 and Rk1. The last two are exclusive to specific cooking procedures (black ginseng, sun ginseng, etc.) and rarely found in classical ginsengs. Therefore, they recently have been the subject of multiple studies to validate their impact on metabolic regulation. The experimental data confirmed the efficacy of the ginsenoside tandem in multiple models [13-17]. It should be noted that Rg3 has also been identified as potentially beneficial in these fields (see here). The increasing number of scientific data about these three bioactive ginsenosides and their positive impact on sugar and fats metabolism clearly invites to consider them as an option for early stages of “metabolic imbalance”. 

2.2. Neurological benefits

As for Rg3, Rg5 & Rk1 have recently been identified as beneficial in the neurological area, including depression [18] and sleeping issues [19]. However, most of the literature on the neurological impact of these ginsenosides, is referring to neuroprotective properties [20] including preservation of cognitive capacities [21-22] and positive impact in neurodegenerative models [23]. 

2.3. Cardiovascular effects

Compared to Rg3, scientific data on the cardiovascular benefits of Rg5 & Rk1 are relatively limited and mainly limited to confirmation of cardioprotective [24], vasculoprotective [25] and anti-aggregation activity [26] . However, that does not mean that they are less effective in this field. Indeed, Rg5 have been identified as a strong vasorelaxant ginsenoside [27] with Sildenafil-like activity in the erectile function context [28].

2.4. Potential in oncology

For now, Rg5 & Rk1 have essentially been tested in different breast cancer models, showing good potential [29-32]. However, several studies also suggest an interest in other cancer types [33-39]. It is however too early to say if this ginsenoside tandem is going to present an equivalent potential to Rg3 regarding oncology.
Like Rg3, Rg5 & Rk1 are considered as strongly bioactive forms of ginsenosides. The increasing number of investigations about their health potential seems to indicate they share “classical properties” associated to ginseng, but also suggests a particularly interesting activity in two health fields: Metabolic balance & Erectile functions. Rg5 & Rk1 are rare in classical ginseng. However, they can be found in premium ginseng preparations which were specifically designed to obtain optimized ginsenoside profile with maximal health benefits. Like for Rg3, all this data clearly prove that not every ginsenosides are equal in terms of health benefits and that you should dig deeper into ginsenoside profile if you want an ingredient of “clinical performance”.
REFERENCES
 
[[1] Qian T, Cai Z (2010) – “Biotransformation of ginsenosides Rb1, Rg3 and Rh2 in rat gastrointestinal tracts.?” Chin Med. 2010 May 26;5:19. doi:> 10.1186/1749-8546-5-19.
[2] An K., Shengjie Z., Jinjun S., Liuqing D. (2015) – “Gut microbiota-mediated deglycosylation of ginsenoside Rb1 in rats: in vitro and in vivo insights from quantitative ultra-performance liquid chromatography-mass spectrometry analysis.?” Analytical Methods, 7(15), 6173?6181.”
[3] Kim DH (2018) – “Gut microbiota-mediated pharmacokinetics of ginseng saponins.” J Ginseng Res. 2018 Jul;42(3):255-263. doi: 10.1016/j.jgr.2017.04.011. Epub 2017 Apr 28.
[4] Shin JH, Park YJ, Kim W, Kim DO, Kim BY, Lee H, Baik MY (2019) – “Change of Ginsenoside Profiles in Processed Ginseng by Drying, Steaming, and Puffing.?” J Microbiol Biotechnol. 2019 Feb 28;29(2):222-229. doi:10.4014/jmb.1809.09056.
[5] Ahmed M. Metwaly, Zhu Lianlian, Huang Luqi, Dou Deqiang (2019) – “Black Ginseng and Its Saponins: Preparation, Phytochemistry and Pharmacological Effects?” Molecules. 2019 May 14;24(10). pii: E1856. doi:10.3390/molecules24101856.
[6] Eom SJ., Kim KT., Paik HD. (2018) – “Microbial bioconversion of ginsenosides in Panax ginseng and their improved bioactivities.?” Food Reviews International, 34(7), 698?712.doi:10.1080/87559129.2018.1424183
[7] Cao L, Wu H, Zhang H, Zhao Q, Yin X, Zheng D, Li C, Kim MJ, Kim P, Xue Z, Wang Y, Li Y (2020) – “Highly efficient production of diverse rare ginsenosides using combinatorial biotechnology.?” Biotechnol Bioeng. 2020 Mar 7. doi: 10.1002/bit.27325.
[8] Seo YS, Shon MY, Kong R, Kang OH, Zhou T, Kim DY, Kwon DY (2016) – “Black ginseng extract exerts anti-hyperglycemic effect via modulation of glucose metabolism in liver and muscle.” J Ethnopharmacol. 2016 Aug 22;190:231-40. doi: 10.1016/j.jep.2016.05.060. Epub 2016 May 31.
[9] Park M, Yoo JH, Lee YS, Park EJ, Lee HJ (2020) – “Ameliorative effects of black ginseng on nonalcoholic fatty liver disease in free fatty acid-induced HepG2 cells and high-fat/high-fructose diet-fed mice.” J Ginseng Res. 2020 Mar;44(2):350-361. doi: 10.1016/j.jgr.2019.09.004. Epub 2019 Oct 4.
[10] Lee MR, Kim BC, Kim R, Oh HI, Kim HK, Choi KJ, Sung CK (2013) – “Anti-obesity effects of black ginseng extract in high fat diet-fed mice.” J Ginseng Res. 2013 Jul;37(3):308-49. doi: 10.5142/jgr.2013.37.308.
[11] Kang OH, Shon MY, Kong R, Seo YS, Zhou T, Kim DY, Kim YS, Kwon DY (2017) – “Anti-diabetic effect of black ginseng extract by augmentation of AMPK protein activity and upregulation of GLUT2 and GLUT4 expression in db/db mice.” BMC Complement Altern Med. 2017 Jun 29;17(1):341. doi: 10.1186/s12906-017-1839-4.
[12] Saba E, Jeon BR, Jeong DH, Lee K, Goo YK, Kim SH, Sung CK, Roh SS, Kim SD, Kim HK, Rhee MH (2016) – “Black ginseng extract ameliorates hypercholesterolemia in rats.” J Ginseng Res. 2016 Apr;40(2):160-8. doi: 10.1016/j.jgr.2015.07.003. Epub 2015 Jul 18.
[13] Xiao N, Lou MD, Lu YT, Yang LL, Liu Q, Liu B, Qi LW, Li P (2017) – “Ginsenoside Rg5 attenuates hepatic glucagon response via suppression of succinate-associated HIF-1α induction in HFD-fed mice.” Diabetologia. 2017 Jun;60(6):1084-1093. doi: 10.1007/s00125-017-4238-y. Epub 2017 Mar 9.
[14] Bai L, Gao J, Wei F, Zhao J, Wang D, Wei J (2018) – “Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes.” Front Pharmacol. 2018 May 1;9:423. doi: 10.3389/fphar.2018.00423. eCollection 2018. Review.
[15] Xiao N, Yang LL, Yang YL, Liu LW, Li J, Liu B, Liu K, Qi LW, Li P (2017) – “Ginsenoside Rg5 Inhibits Succinate-Associated Lipolysis in Adipose Tissue and Prevents Muscle Insulin Resistance.” Front Pharmacol. 2017 Feb 14;8:43. doi: 10.3389/fphar.2017.00043. eCollection 2017.
[16] Ponnuraj SP, Siraj F, Kang S, Noh HY, Min JW, Kim YJ, Yang DC (2014) – “Amelioration of insulin resistance by Rk1 + Rg5 complex under endoplasmic reticulum stress conditions.” Pharmacognosy Res. 2014 Oct;6(4):292-6. doi: 10.4103/0974-8490.138257.
[17] Yesmin Simu S, Ahn S, Castro-Aceituno V, Yang DC (2017) – “Ginsenoside Rg5: Rk1 Exerts an Anti-obesity Effect on 3T3-L1 Cell Line by the Downregulation of PPARγ and CEBPα.” Iran J Biotechnol. 2017 Dec 29;15(4):252-259. doi: 10.15171/ijb.1517. eCollection 2017.
[18] Xu D, Wang C, Zhao W, Gao S, Cui Z (2017) – “Antidepressant-like effects of ginsenoside Rg5 in mice: Involving of hippocampus BDNF signaling pathway.” Neurosci Lett. 2017 Apr 3;645:97-105. doi: 10.1016/j.neulet.2017.02.071. Epub 2017 Mar 1.
[19] Shao J, Zheng X, Qu L, Zhang H, Yuan H, Hui J, Mi Y, Ma P, Fan D (2020) – “Ginsenoside Rg5/Rk1 ameliorated sleep via regulating the GABAergic/serotoninergic signaling pathway in a rodent model.” Food Funct. 2020 Feb 13. doi: 10.1039/c9fo02248a.
[20] Lee YY, Park JS, Jung JS, Kim DH, Kim HS (2013) – “Anti-inflammatory effect of ginsenoside Rg5 in lipopolysaccharide-stimulated BV2 microglial cells.” Int J Mol Sci. 2013 May 8;14(5):9820-33. doi: 10.3390/ijms14059820.
[21] An KS, Choi YO, Lee SM, Ryu HY, Kang SJ, Yeon Y, Kim YR, Lee JG, Kim CJ, Lee YJ, Kang BJ, Choi JE, Song KS (2019) – “Ginsenosides Rg5 and Rk1 Enriched Cultured Wild Ginseng Root Extract Bioconversion of Pediococcus pentosaceus HLJG0702: Effect on Scopolamine-Induced Memory Dysfunction in Mice.” Nutrients. 2019 May 20;11(5). pii: E1120. doi: 10.3390/nu11051120.
[22] Kim EJ, Jung IH, Van Le TK, Jeong JJ, Kim NJ, Kim DH (2013) – “Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice.” J Ethnopharmacol. 2013 Mar 7;146(1):294-9. doi: 10.1016/j.jep.2012.12.047. Epub 2013 Jan 9.
[23] Chu S, Gu J, Feng L, Liu J, Zhang M, Jia X, Liu M, Yao D (2014) – “Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses.” Int Immunopharmacol. 2014 Apr;19(2):317-26. doi: 10.1016/j.intimp.2014.01.018. Epub 2014 Feb 4.
[24] Yang YL, Li J, Liu K, Zhang L, Liu Q, Liu B, Qi LW (2017) – “Ginsenoside Rg5 increases cardiomyocyte resistance to ischemic injury through regulation of mitochondrial hexokinase-II and dynamin-related protein 1.” Cell Death Dis. 2017 Feb 23;8(2):e2625. doi: 10.1038/cddis.2017.43.
[25] Maeng YS, Maharjan S, Kim JH, Park JH, Suk Yu Y, Kim YM, Kwon YG (2013) – “Rk1, a ginsenoside, is a new blocker of vascular leakage acting through actin structure remodeling.” PLoS One. 2013 Jul 22;8(7):e68659. doi: 10.1371/journal.pone.0068659. Print 2013.
[26] Lee JG, Lee YY, Kim SY, Pyo JS, Yun-Choi HS, Park JH (2009) – “Platelet antiaggregating activity of ginsenosides isolated from processed ginseng.” Pharmazie. 2009 Sep;64(9):602-4.
[27] Cho YL, Hur SM, Kim JY, Kim JH, Lee DK, Choe J, Won MH, Ha KS, Jeoung D, Han S, Ryoo S, Lee H, Min JK, Kwon YG, Kim DH, Kim YM (2015) – “Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation.” J Biol Chem. 2015 Jan 2;290(1):467-77. doi: 10.1074/jbc.M114.603142. Epub 2014 Nov 12.
[28] Ying A, Yu QT, Guo L, Zhang WS, Liu JF, Li Y, Song H, Li P, Qi LW, Ge YZ, Liu EH, Liu Q (2018) – “Structural-Activity Relationship of Ginsenosides from Steamed Ginseng in the Treatment of Erectile Dysfunction.” Am J Chin Med. 2018;46(1):137-155. doi: 10.1142/S0192415X18500088. Epub 2018 Jan 3.
[29] Liu Y, Fan D (2019) – « The Preparation of Ginsenoside Rg5, Its Antitumor Activity against Breast Cancer Cells and Its Targeting of PI3K.” Nutrients. 2020 Jan 18;12(1). pii: E246. doi: 10.3390/nu12010246.
[30] Hong Y, Fan D (2019) – “Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.” Toxicology. 2019 Apr 15;418:22-31. doi: 10.1016/j.tox.2019.02.010. Epub 2019 Feb 21.
[31] Liu Y, Fan D (2018) – “Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.” Food Funct. 2018 Nov 14;9(11):5513-5527. doi: 10.1039/c8fo01122b.
[32] Kim SJ, Kim AK (2015) – “Anti-breast cancer activity of Fine Black ginseng (Panax ginseng Meyer) and ginsenoside Rg5.” J Ginseng Res. 2015 Apr;39(2):125-34. doi: 10.1016/j.jgr.2014.09.003. Epub 2014 Oct 18.
[33] Feng SL, Luo HB, Cai L, Zhang J, Wang D, Chen YJ, Zhan HX, Jiang ZH, Xie Y (2020) – “Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study. » J Ginseng Res. 2020 Mar;44(2):247-257. doi: 10.1016/j.jgr.2018.10.007. Epub 2018 Nov 8.
[34] Hu M, Yang J, Qu L, Deng X, Duan Z, Fu R, Liang L, Fan D (2020) – “Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma.” Food Funct. 2020 Jan 29;11(1):456-471. doi: 10.1039/c9fo02166c.
[35] Zhang D, Wang A, Feng J, Zhang Q, Liu L, Ren H (2019) – “Ginsenoside Rg5 induces apoptosis in human esophageal cancer cells through the phosphoinositide‑3 kinase/protein kinase B signaling pathway.” Mol Med Rep. 2019 May;19(5):4019-4026. doi: 10.3892/mmr.2019.10093. Epub 2019 Mar 27.
[36] Oh JM, Lee J, Im WT, Chun S (2019) – “Ginsenoside Rk1 Induces Apoptosis in Neuroblastoma Cells Through Loss of Mitochondrial Membrane Potential and Activation of Caspases.” Int J Mol Sci. 2019 Mar 11;20(5). pii: E1213. doi: 10.3390/ijms20051213.
[37] Cui Y, Su Y, Deng L, Wang W (2018) – “Ginsenoside-Rg5 Inhibits Retinoblastoma Proliferation and Induces Apoptosis through Suppressing BCL2 Expression.” Chemotherapy. 2018;63(5):293-300. doi: 10.1159/000495575. Epub 2019 Feb 7.
[38] Liu Y, Fan D (2018) – “Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer.” Biochem Pharmacol. 2019 Oct;168:285-304. doi: 10.1016/j.bcp.2019.07.008. Epub 2019 Jul 10.
[39] Liang LD, He T, Du TW, Fan YG, Chen DS, Wang Y (2015) – “Ginsenoside‑Rg5 induces apoptosis and DNA damage in human cervical cancer cells.” Mol Med Rep. 2015 Feb;11(2):940-6. doi: 10.3892/mmr.2014.2821. Epub 2014 Oct 30.